EDGAR Filing Documents for 0001628280-22-026884

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:

SEC Accession No. 0001628280-22-026884

Filing Date

2022-10-24

Accepted

2022-10-24 16:17:45

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	DEFA14A	defa14adraft.htm	DEFA14A	7749
2		image1a.jpg	GRAPHIC	417050
3		image_0a.jpg	GRAPHIC	126
4		imagea.jpg	GRAPHIC	602428
	Complete submission text file	0001628280-22-026884.txt		1413452

Mailing Address 3730 KIRBY DRIVE SUITE 1200 HOUSTON TX 77098

Business Address 3730 KIRBY DRIVE SUITE 1200 HOUSTON TX 77098 (832) 384-1100

BELLICUM PHARMACEUTICALS, INC (Filer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36783 | Film No.: 221326242
SIC: 2834 Pharmaceutical Preparations